Could a turmeric compound shield Smokers' blood vessels?
NCT ID NCT01543386
First seen Aug 05, 2026 · Last updated Aug 06, 2026 · Updated 1 time
Summary
This trial tests whether a high dose of curcumin, the active compound in turmeric, can improve the function of blood vessels in healthy middle-aged smokers. Participants aged 50 to 70 who smoke will receive curcumin, and researchers will measure changes in how well their blood vessels dilate. The goal is to see if curcumin might help counteract some of the cardiovascular risks associated with smoking.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- curcumin
- What this could lead to
- If curcumin improves blood vessel function, it could point toward a simple supplement to help reduce cardiovascular risk in smokers.
- What could go wrong
- This is an early, small trial, so results may not be conclusive. Curcumin's effects on vascular health are not yet proven, and individual responses may vary.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS (MIDDLE-AGED SMOKERS) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU Clermont-Ferrand
Clermont-Ferrand, 63003, France